InDex Pharmaceuticals Holding AB (publ) year end report 2016
Focus on the final preparations of the CONDUCT studyPeriod October – December 2016 · Revenues amounted to SEK 0.3 (0.1) million · Operating result amounted to SEK -16.4 (-6.4) million · Result after tax amounted to SEK -16.3 (-6.5) million, corresponding to SEK -0.27 per share (-0.22) before and after dilution · Cash flow from operating activities amounted to SEK -8.3 (-7.3) million Period full year 2016 · Revenues amounted to SEK 0.4 (0.4) million · Operating result amounted to SEK -39.5 (-29.5) million · Result after tax amounted to SEK -41.3 (-29.9) million,